Shows

Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down

For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects, according to a 20-year follow-up of a randomized trial, which appears in the January 19 issue of the Journal of the National Cancer Institute. The British Columbia randomized radiation the...

UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims

UCLA investigators reviewed pharmaceutical ads in American medical journals and found that nearly one-third contained no references for medical claims; while the majority of references to published material was available, only a minority of company data-on-file documents were provided upon request; and the majority of original research cited in the ads was funded by or had authors affiliated with...

Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer

The genome sequence of the parasitic amoeba Entamoeba histolytica, a leading cause of severe diarrheal disease in developing countries, includes an unexpectedly complex repertoire of sensory genes as well as a variety of bacterial-like genes that contribute to the organism's unique biology. The report, which appears in the February 24 issue of Nature, presents the first genome-wide study...

“Nano-scissors?laser shows precise surgical capability

)is quite a challenge; its about 1 mm in length. A research team fromthe University of Texas at Austin developed a method of laser-assistedsurgery to work on these little beasts, being able to section a singleaxon (the "arms" of a neuron) with g...

Novel Enzyme Shows Potential As An Anti-HIV Target

At just 9.8 kilobases, the HIV genome pales in comparison to the 3.2 gigabases of its human and nonhuman primate targets. The compact retrovirus encodes just 14 proteins, which play different roles in promoting viral infection and virulence. As a retrovirus, HIV uses the host’s cellular machinery—including RNA polymerases, which carry out transcription—to copy its RNA genome into DNA and infiltra...

More>>

Shows at Biology Products

No data found

Search Shows biology products at Google

Search Shows biology products at Yahoo

Search Shows biology products at Msn

Shows at Biology Technology

Blurb shows that print still captures imaginations

There's no clearer example than . I first discussed Blurb with founder Eileen Gittens when the company was no more than a brief <a href="http://www.office.microsoft.com...

Kauffman study shows consistent entrepreneurial growth

...

Directory shows high-tech growth spurt in Dane Co.

<a href="https://wistechnology.com/h...

Stem cell therapy shows visionary promise

In a study in rats, neural progenitor cells derived from human fetal stem cells have been shown to protect the vision of animals with degenerative eye disease similar to the kinds of diseases that afflict...

TDS restates years of revenues, shows slight profit drop

Phone and data company TDS, also the corporate parent of U.S. Cellular, said its revenues for the last quarter were $1 billion, an increase over results from last year that it had to restate due to accounting problems. Net income for the quarter was $41.5 million, down from $43.3 million in the same quarter a year ago. TDS said in November 2005 it would have to restate some resu...

More>>

Shows at Medicine News

Experimental treatment for Ebola Virus Shows promising results in mice

Scientists at the Center for Disease Control and Prevention (CDC) in Atlanta, Georgia, have said that an experimental treatment for the deadly Ebola virus has shown promising results in mice. In the study, researchers led by Dr. Manish Gupta took antibodies from the immune systems of mice that had survived infection with the deadly Ebola virus and injected them into other Ebola-free mice...

Gene Therapy shows promise in treating Hemophilia

Researchers at Beth Israel Deaconess Medical Center reported in the current New England Journal of Medicine that an experimental Gene Therapy method has safely introduced new genes into six men suffering from hemophilia. This method shows signs of helping these men fight the disease by producing the blood clotting protein they lack. None of the patients suffers side effects even after o...

San Francisco Shows Marginal Decrease In AIDS Infection

Health officials of San Francisco stated that there has been nearly a 10 percent drop in the HIV infected case in the past five years, but also added that their job is far from done.// The city's Department of Public Health had expected new HIV infections to rise 33 percent given an increase in the number of case of syphilis, epidemiologist Willi McFarland told The Los Angeles Times, rep...

New Prostate Cancer Vaccine Shows Promise

Preliminary results from a study on a vaccine made from the immune system cells of prostate cancer patients show it to be a promising. Dr. Johannes Vieweg, associate professor of urology and an assistant professor of immunology at Duke University Medical Center in Durham, tested the vaccine on 13 men with metastatic prostate cancer.// The vaccine uses the men's own dendritic cells, ex...

Leukemia pill shows promise against stomach cancer

Gleevec, which was just approved for treating leukemia, also shows promise against a type of stomach cancer . The Food and Drug Administration approved the use of a promising anti-leukemia drug for treatment of a relatively rare form of abdominal cancer. The drug, Gleevec, administered as a pill once a day, is effective in treating both forms of cancer because of its ability to target and...

More>>

Shows at Medicine Products

No data found

Search Shows medicine products at Google

Search Shows medicine products at Yahoo

Search Shows medicine products at Msn

Shows at Medicine Technology

Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs

IRVING, Texas--(BUSINESS WIRE)--Jul 11, 2007 - The Journal of theAmerican Society of Clinical Oncology has published the earlyresults of a clinical study conducted by Dr. Siu-Fun Wong, and hercolleagues, which concluded that the topical gel, Regenecare(R),caused a statistically significant reduction in the pain anditching of a rash that results from the use of anti-cancer drugsknown as EGFR...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

- ENDORSE Global Findings Highlight the Need to UrgentlyImplement Hospital-Wide Strategies to Optimize VTE Management:Systematically Assess Patient Risk for VTE and Provide Appropriateprophylaxis to Prevent VTE Venous thromboembolism (VTE) risk is high among hospitalpatients and most of these at-risk patients are not pro...

New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility

EXCLAIM is the First International Study to Show That ExtendedThromboprophylaxis Reduces VTE Risk in Acutely-ill Medical PatientsWith a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventisannounced today the results of the EXCLAIM (EXtended CLinicalprophylaxis in Acutely Ill Medical patients) study, which showedthe benefit of extended prophylaxi...

MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial

MARTINSRIED/MUNICH, Germany, July 9, 2007-A virus that has beenspecifically designed by scientists to be safe to normal tissue butdeadly to cancer is showing early promise in a preliminary study,researchers said today at the ESMO Conference Lugano (ECLU),Switzerland. The virus, called NV1020, is a type of herpes simplex virusmodified so that it selectively replicates in virus cells...

Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine

- Phase II Results Published in the Journal of Clinical Oncology - NEW YORK, July 06, 2007 /PRNewswire-FirstCall/ -- Results from aPhase II study - which will be published in the August 10, 2007issue of the Journal of Clinical Oncology (JCO) and are nowavailable as an Early Release Article at <a target="_blank" href="http://www.jco.org/">www.jco.org - demonstrate thatixabepilone, a Br...

More>>